Madadi Reza, Bakhshaei Sina, Tavasol Arian, Gorjizad Mahmood, Hemmati Rouhollah, Zangi Masood
Interventional Cardiologist, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Cardiovascular Fellow, UHS Southwest Healthcare MEC, Temecula, CA, United States.
J Saudi Heart Assoc. 2025 Jun 1;37(2):14. doi: 10.37616/2212-5043.1432. eCollection 2025.
Cardiovascular events are the most common cause of mortality worldwide. Various studies have shown the relationship between serum 25-hydroxyvitamin D [25(OH)Vit D] levels and cardiovascular events. The purpose of this study is to investigate the meta-analysis of the relationship between serum 25(OH)Vit D levels and the risk of cardiovascular diseases (CVD), including stroke, coronary heart disease, peripheral arterial disease, and aortic disease in the population.
Using valid keywords and searching the Medline, Science Direct, Scopus, and Web of Science databases, 22 papers were compiled. Data analysis was performed in the group of people with low serum 25(OH)Vit D levels (<75 nmol/L). The data were analyzed using a random-effects meta-analysis model with R and Stata Version 17.0 software.
In this study, 22 papers were included. This meta-analysis of 12 cohort studies (n = 39,396) found that lower serum vitamin D levels were significantly associated with increased risk of cardiovascular disease (HR = 1.38, 95 % CI: 1.24-1.53) and all-cause mortality (HR = 1.64, 95 % CI: 1.33-2.03). Dose-response analysis showed that each 10 nmol/L increase in vitamin D reduced CVD risk by 8.2 % (HR = 0.992, 95 % CI: 0.990-0.993). A non-linear inverse association was observed for all-cause mortality, with stronger protective effects at lower vitamin D levels. These results, in addition to most of the studies included in the systematic review, support a potential protective role of higher vitamin D concentrations.
The results of this study showed a relationship between serum 25(OH)Vit D levels and cardiovascular outcomes; the lower the serum 25(OH)Vit D level, the higher the risk of cardiovascular disease.
心血管事件是全球最常见的死亡原因。各种研究表明了血清25-羟基维生素D[25(OH)Vit D]水平与心血管事件之间的关系。本研究的目的是对人群中血清25(OH)Vit D水平与心血管疾病(CVD)风险之间的关系进行荟萃分析,这些心血管疾病包括中风、冠心病、外周动脉疾病和主动脉疾病。
使用有效关键词并检索Medline、Science Direct、Scopus和Web of Science数据库,共收集到22篇论文。对血清25(OH)Vit D水平低(<75 nmol/L)的人群进行数据分析。使用R和Stata 17.0软件的随机效应荟萃分析模型对数据进行分析。
本研究纳入了22篇论文。对12项队列研究(n = 39,396)的荟萃分析发现,较低的血清维生素D水平与心血管疾病风险增加(HR = 1.38,95%CI:1.24 - 1.53)和全因死亡率增加(HR = 1.64,95%CI:1.33 - 2.03)显著相关。剂量反应分析表明,维生素D每增加10 nmol/L,CVD风险降低8.2%(HR = 0.992,95%CI:0.990 - 0.993)。观察到全因死亡率呈非线性负相关,在较低维生素D水平时保护作用更强。这些结果,除了系统评价中纳入的大多数研究外,支持了较高维生素D浓度的潜在保护作用。
本研究结果表明血清25(OH)Vit D水平与心血管结局之间存在关联;血清25(OH)Vit D水平越低,心血管疾病风险越高。